Private practice Endocrinology and Internal Medicine, Beverly Hills, California

Transcription

1 Jordan Geller, M.D Century Park East, Suite 1812 Los Angeles, California I am a board-certified Internist and Endocrinologist, specializing in the diagnosis and treatment of complex metabolic disorders. In addition to a fulltime medical practice, I am a clinical instructor at the UCLA School of Medicine and have authored numerous publications in the field of Endocrinology. Medical Practice Private practice Endocrinology and Internal Medicine, Beverly Hills, California Past Clinical Chief, Cedars-Sinai Medical Center Division of Endocrinology, Diabetes and Metabolism Clinical Instructor, UCLA Geffen School of Medicine Cedars-Sinai Cancer Thyroid Center of Excellence Education Postdoctoral fellow, Division of Endocrinology, Diabetes and Metabolism Cedars-Sinai Medical Center, Los Angeles, California. June 2006 National Institutes of Health K30 Clinical Research Fellow, Human Participants Protection Certificate in Clinical Research, National Institutes of Health, 2005 Certificate in Clinical Investigation, UCLA General Clinical Research Center, 2004 Certificate in Principles of Clinical Pharmacology, National Institutes of Health, 2004 Resident in Internal Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles California, 2004 Certificate in Human Subjects Protection Principles, Burns and Allen Research Institute, Cedars- Sinai Medical Center, Los Angeles, CA, 2003 Doctor of Medicine, University of Southern California Keck School of Medicine, Los Angeles, 2001 Bachelor of Arts, Cum Laude Loyola Marymount University, Los Angeles, California, 1993

2 Memberships Diplomat of the American Board of Internal Medicine Diplomat of the American Board of Endocrinology, Diabetes and Metabolism Expert reviewer, Medical Board of California Former Editorial Board Member, Clinical Nutrition Insight Reviewer Journal of Bone and Mineral Research Honors American Thyroid Association Fellow s Track Recipient, Baltimore, 2005 National Institutes of Health Clinical Research Loan Repayment Program recipient, 2004 California Medical Assoc. Legislative Seminar grant recipient, Sacramento, 2001 Pathology Honors Program, University of Health Sciences, 1999 American Pediatric Society Research Fellowship 1998 Rutger s University Fellowship for Advanced School of Alcohol and Drug Studies, 1998 Leichtling Oncology Research Award (deferred), 1998 Illinois Academy of Family Physicians Externship, 1998 Summer Research Fellow, Univ. Health Sciences, 1997 Cum Laude Honors, Loyola Marymount University, 1993 Outstanding Graduate in Department of Sociology, Loyola Marymount Univ 2003 Presenter, Santa Clara University Sociology Research Conference, 1993, 1994 Dean s List, Santa Monica College, 1989 Publications Liu NA, Sacks W and Geller JL, Geller Epocrates Osteoporosis Curriculum 2010; Epocrates, Inc. Adams JS. Reply to: Increase in Bone Mass after Vitamin D Replacement: Can We Ignore Regression to the Mean? Endocr Pract. 2008;14;5 Geller JL, Adams JS. Vitamin D Therapy. Current Osteoporosis Reports 2008

3 Cooper OB, Geller JL and Melmed S. Ovarian Hyperstimulation Syndrome caused by an FSH- Secreting Pituitary Adenoma. Nat Clin Pract Endocrinol Metab. Feb 12, 2008 Geller JL, Hu B, Reed S, Mirocha J and Adams JS. Repair of Vitamin D Insufficiency Increases Bone Mass in Bisphosphonate-Treated Patients. Endo Prac. 2008; 14:3 Geller JL Vitamin D: The Sunshine Hormone. Food Technology, June 2007 Geller JL, Adams, JS. Proton Pump Inhibitor Therapy and Hip Fracture Risk. JAMA. 2007; 297:1429 Geller JL, Azarmindokht K, Kelly MH, et al. Clinical Vignette: Cinacalcet in the Management of Tumor-Induced Osteomalacia. J Bone Min Res. 2007; Mar 12 Geller JL The Way I see it: Healthcare Reform Begins with Patient. Medical Economics. Dec 15, 2006 Karakelides H, Geller JL, Schroeter AL, Chen H, Behn PS, Adams JA, Hewison M, Wermers RA. Vitamin D-mediated hypercalcemia in slack skin disease: further evidence for extra-renal expression of 25-hydroxyvitamin D-1α-hydroxylase in granulomatous disorders. J Bone Min Res Sep; Geller JL, Azer P, Mertens, RB, Weiss LM. Recurrent and Metastatic Pigmented Adrenocrotical Carcinoma:case report and review. Endocr Pathol. 2006; 17: Geller JL, Braunstein GB. Dermatological Manifestations of Hypopituitarism. Clinics in Dermatology. 2006; 42: Geller JL. Borrowing Against the Bones: The Price of Eucalcemia. Nutrition and the M.D. 2006; 32:5 Geller JL, Adams JS. Statins and Fracture: All Variables Accounted For? Archives of Internal Medicine 2006; 166:1041 Geller JL, Arteaga V, Fan X, Yu J. A Symptomatic Prolactinoma Co-existing within a Rathke s Cleft Cyst Invading Bone: Case Report and Review. Endocrinol 2006; Geller, JL, Mertens, RB and Weiss LM. Adrenocortical Carcinoma: Many Questions Remain Unanswered. The Endocrinologist, 2005; 15: Abreu MT, Kam LY, Vasiliauskas EA, Vora P, Adams JS, Yang H, Geller JL, Hu B, Lin YC, Keenan G, Price J, Landers CJ, Targan SR. Treatment with Infliximab is Associated With Increased Markers of Bone Formation in Patients With Crohn's Disease. Journal of Clinical Gastroenterology, 2006; 40: Geller JL, Hackner D. Prolonged Refractory Streptococcal Toxic Shock Syndrome Complicated by Pulmonary Thromboemboli: Case Report and Review. Annals of Hematology Apr 7 Bhushan V, Pall V, Le T, Yen YM, Geller JL, Gupta S. Clinical Science Color Atlas. Blackwell, 2002

4 Abstracts Geller JL, Reed, S, Mirocha J, Adams JS. Vitamin D Insufficiency and Unresponsiveness to Bisphosphonates. Cleveland Clinic Bone Innovation Summit, May 5, JL. Geller, C. Cutler, M. H. Kelly, J. S. Adams, M. T. Collins. Cinacalcet Is Associated with Decreased Serum FGF-23 and Improved Phosphorous Homeostasis in Patients with Tumor-Induced Osteomalacia. The 27th Annual Meeting of the American Society for Bone and Mineral Research, Nashville, Tennessee, Wermers RA, Karakelides H, Adams JS, Chen H, Geller JL, Hewison M. Vitamin D-Mediated Hypercalcemia in Granulomatous Slack Skin Disease: Evidence for the Extra-renal 1- Hydroxylation of 25-hydroxvitamin D in Involved Skin Granulomata. Endocrine Society 87th Annual Meeting, San Diego, 2005 Geller JL, Azer P, Mertens, RB, Weiss LM. Recurrent and Metastatic Pigmented Adrenocortical Carcinoma. Endocrine Society 87th Annual Meeting, San Diego, 2005 Abreu MT, Kam LY, Vasiliauskas EA, Vora P, Adams JS, Yang H, Geller JL, et al. Treatment with Infliximab is Associated With Increased Markers of Bone Formation in Patients With Crohn's Disease. American Society for Bone and Mineral Research, 26th Annual Meeting, Seattle, WA, 2004 Lectures and Seminars Identification and Treatment of Secondary Causes of Osteoporosis. American Association of Clinical Endocrinologists 13th Annual Meeting and Symposium October 5, 2013 Hypothyroidism and the Importance of Patient-Physician Dialogue. Abbvie, Inc. Trump Soho, April 17, 2013 Management of Autoimmune Thyroid Disease in Patients Undergoing IVF Southern California Reproductive Center, June 13, 2011 The Conundrum of Normocalcemic Hyperparathyroidism Cedars-Sinai Thyroid Grand Rounds, March 24, 2011 The Spectrum of Primary Hyperparathyroidism. Cedars-Sinai Thyroid Disease Symposium, Mar11, 2011 The Spectrum of Primary Hyperparathyroidism. Cedars-Sinai Thyroid Disease Symposium, March 15, 2009 Osteoporosis: Not Just Your Grandmother s Disease. Cedar's-Sinai Center for International Health & Telemedicine. January 29, 2009

5 Osteoporosis Myths. Tarzana Medical Center Calcium Metabolism Symposium. November 11, 2008 Common Endocrine Issues in the Hospitalized Patient. Society for Hospital Medicine April 5, 2008 Key Concepts in Bone Mineral Densitometry Cedars-Sinai Medical Center, Feb 28, 2008 Exploiting the Calcium-Sensing Receptor in the Management of Hypophosphatemic Osteomalacia. Harbor UCLA Endocrine Clinical Conference, November 7, 2007 The Top 10 Vitamin D Myths. West Los Angeles VA Hospital Endocrine Grand Rounds, Sept 28, 2007 A Fast Acting Goiter. Cedars-Sinai Thyroid Cancer Center Multidisciplinary Conference June 28, 2007 Osteoporosis Myths, Legends, Rumors and Lies. Cedars-Sinai Medical Grand Rounds, June 1, 2007 Hyperparathyroidism and Beyond: Expanding the Role of Calcium-Sensing Receptor Suppression. Cedars-Sinai Medical Center Endocrine Grand rounds, Feb 13, 2000 Vitamin D Dysregulation Cedars-Sinai Medical Center Internal Medicine Grand rounds, January 11, Gonadotropin Secreting Pituitary Adenoma with Ovarian Hyperstimulation. Cedars-Sinai Pituitary Center Interdisciplinary Pituitary Case Conference, November 28, American Board of Internal Medicine Endocrinology Review. Cedars-Sinai Medical Center, June 19, The Association of Vitamin D Insufficiency with a Declining Response to Bisphosphonates. Cleveland Clinic Bone Innovation Summit. May 4, Principles of Bone Densitometry. Cedars-Sinai Endocrinology Teaching Seminar, May 1, Familial Nonmedullary Thyroid Carcinoma. Cedars-Sinai Medical Center Thyroid Cancer Grand Rounds, January 26, Metastatic Pheochromocytoma: Management. Cedars-Sinai Medical Center Carcinoid and Neuroendocrine Tumor Center Interdisciplinary Conference, November 15, Cinacalcet in the Management of FGF-23-Mediated Hypophosphatemia. American Society for Bone and Mineral Research, Bone and Mineral Working Group, September 26, 2005 Metastatic Pheochromocytoma: Clinical Presentation. Cedars-Sinai Medical Center Carcinoid and Neuroendocrine Tumor Center Interdisciplinary Conference, July 21, What is Off-Label? UCLA K30 Journal Club, June 14th, 2005.

6 American Board of Internal Medicine Endocrinology Review. Cedars-Sinai Medical Center, May 30, A Case of an Invasive Prolactinoma. Cedars-Sinai Pituitary Center Interdisciplinary Pituitary Case Conference, March 29, Prolactinoma within a Rathke s Cleft Cyst Invading Bone. Cedars-Sinai Pituitary Center Interdisciplinary Pituitary Case Conference, February 1, Metabolic Bone Disease. Cedars-Sinai Medical Center, Medicine Grand Rounds, December 21, Effect of Oral Alendronate on Bone Mineral Density. UCLA K30 Journal Club July 16, 2004.